Studies of the methylation status of the CDKN1A promoter in bone marrow cells in 124 patients with acute lymphoblastic leukaemia showed hypermethylation in 41% (51 of 124) of these patients. This evidence concerns the gene CDKN1A and acute lymphoblastic leukemia.